Abstract:Human serum albumin (HSA) is a crucial protein in the human body, serving as a carrier for various small molecules and playing a vital role in maintaining osmotic pressure in the bloodstream. However, misfolding and fibrillation of HSA can lead to a range of pathological conditions, including amyloidosis. In recent years, researchers have explored several innovative strategies to inhibit HSA fibrillation, and one of the promising avenues is the utilization of chiral compounds that can offer an effective means of modulating the 'structural integrity of the protein. Among the most prevalent chiral compounds, chiral carbon dots (CCDs) are renowned for their distinctive physicochemical properties, offering unique stereochemical properties, assuming a pivotal role in attaining circularly polarized luminescence that can be harnessed for inhibiting HSA fibrillation. Recent advancement of carbon-based chiral nanostructures has attracted widespread attention in the field of nanobiotechnology owing to their overwhelming chemical, optical and electronic properties. However, being an emerging type of chiral nanomaterial, chiral CDs (CCDs) are still at their primary research stage. Herein, we have developed a simple methodology to quickly synthesize chiral carbon dots ( L / D -TA-C-dots) of size ranging from 3 to 7 nm by microwave-assisted pyrolysis of L / D -tartaric acid, respectively. The circular dichroism spectrum of L / D -TA-C-dots has demonstrated characteristic peaks with opposite nature at around 230–232 nm corresponding to the n → π* transition of CO groups. The synthesized L / D -C-dots have exhibited stable and intense luminescence at 460 nm. A variety of biophysical techniques such as thioflavin-T fluorescence, circular dichroism, fluorescence microscopy, transmission electron microscopy and atomic force microscopy have suggested that the L -TA-C-dots are more effective in hindering the fibrillation process of HSA than D -TA-C-dots. Further, the potential of the synthesized L -TA-C-dots to inhibit the formation of human serum albumin (HSA) fibrils has been investigated in vitro . The biocompatibility of water-soluble L -TA-C-dots has been confirmed by determining the cellular uptake efficiency through a localization study after exposing them to MDA-MB-231 cells. Besides, the thermodynamic parameters for the interaction of HSA monomers with L / D -TA-C-dots have also been calculated, which suggests that the preferential hydrophobic interaction between HSA monomers and L -C-dots restricts the self-assembly of HSA at an early stage, leading to inhibition of fibrillation. The promising results of chiral L -TA-C-dots provide an opportunity to exploit them in the field of in vivo bioimaging and can be used as promising therapeutic agents for various amyloidogenic disorders.

Chiral carbon dots: a smart choice for inhibition of human serum albumin fibrillation

Synthesis of aspartic acid-derived chiral carbon dots and their effect on bovine serum albumin amyloid fibrillation by multispectral and molecular interaction studies

Morphological Effects of CuO Nanostructures on Fibrillation of Human Serum Albumin

Active Site-Targeted Carbon Dots for the Inhibition of Human Insulin Fibrillation

Dopamine-Conjugated Carbon Dots Inhibit Human Calcitonin Fibrillation

Synthesis of Cationic Carbon Dots and Their Effects on Human Serum Proteins and in Vitro Blood Coagulation

Unraveling the impact of tungsten disulfide quantum dots on human serum albumin conformational dynamics and fibrillation pathways: An integrated multi-spectroscopic, biochemical, and molecular docking investigation

Amine Group Surface-Functionalized Carbon Quantum Dots Exhibit Anti-amyloidogenic Effects Towards Hen Egg White Lysozyme by Inducing Formation of Nontoxic Spherical Aggregates

Amyloid Inhibitors: Lysine-Derived Carbon Dots for Chiral Inhibition of Prion Peptide Fibril Assembly (Adv. Therap. 4/2018)

Biophysical insight into anti-amyloidogenic nature of novel ionic Co(II)(phen)(H2O)4]+[glycinate]- chemotherapeutic drug candidate against human lysozyme aggregation

Effect of 4-mercaptophenylboronic acid functionalized MoS 2 quantum dots on amyloid aggregation of bovine serum albumin

Hydrothermal synthesis of chiral carbon dots

Cysteine-Derived Chiral Carbon Quantum Dots: A Fibrinolytic Activity Regulator for Plasmin to Target the Human Islet Amyloid Polypeptide for Type 2 Diabetes Mellitus

Fibrillation of Human Serum Albumin Differentially Affected by Asp-, Arg-, and Tyr-Capped Gold Nanoparticles

Inhibition of amyloidal aggregation of insulin by amino acid conjugated bile acids: An insight into the possible role of biosurfactants in modulating the fibrillation kinetics and cytotoxicity

Chiral nanomaterials-based approaches for diagnosis and treatment of protein aggregated neurodiseases: current status and future opportunities

Real-Time 3D Imaging and Inhibition Analysis of Human Serum Amyloid A Aggregations Using Quantum Dots

Chiral effect on Aβ fibrillation from molecular-scale to nanoscale

Effect of (−)-epigallocatechin gallate on the fibrillation of human serum albumin

Carboxylic Group Functionalized Carbon Quantum Dots inhibit Hen Egg White Lysozyme Amyloidogenesis, leading to the Formation of Spherical Aggregates with Reduced Toxicity and ROS Generation

Investigation on conformational variation and fibrillation of human serum albumin affected by molybdenum disulfide quantum dots